PMID,PMC_ID,Title,Citation_Count,Authors,Journal,Year,DOI,DOI_Link,PDF_Link,PubMed_URL
38786024,PMC11119143,CRISPR-Based Gene Therapies: From Preclinical to Clinical Treatments.,32,"Laurent M, Geoffroy M, Pavani G",Cells,2024,10.3390/cells13100800,https://doi.org/10.3390/cells13100800,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11119143/pdf/,https://pubmed.ncbi.nlm.nih.gov/38786024/
27699445,PMC5434172,CRISPR/Cas9 Immune System as a Tool for Genome Engineering.,78,"Hryhorowicz M, Lipiński D, Zeyland J",Archivum immunologiae et therapiae experimentalis,2016,10.1007/s00005-016-0427-5,https://doi.org/10.1007/s00005-016-0427-5,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5434172/pdf/,https://pubmed.ncbi.nlm.nih.gov/27699445/
26470680,N/A,Advances in therapeutic CRISPR/Cas9 genome editing.,101,"Savić N, Schwank G",Translational research : the journal of laboratory and clinical medicine,2015,10.1016/j.trsl.2015.09.008,https://doi.org/10.1016/j.trsl.2015.09.008,N/A,https://pubmed.ncbi.nlm.nih.gov/26470680/
